Clinical trial
Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia
NCT00442676 · Virginia Commonwealth University, Other · Withdrawn
Key facts
| NCT number | NCT00442676 |
|---|---|
| Title | Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia |
| Official title | Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia |
| Lead sponsor | Virginia Commonwealth University, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Preeclampsia |
| Intervention type | Drug |
| Interventions | Celecoxib, Placebo |
| Enrollment | 0 |
| Start date | Jun 1, 2009 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Mar 2, 2007 |
| Last update posted | Mar 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: